Stage IVB Oropharyngeal Squamous Cell Carcinoma Recruiting Phase 1 Trials for Berzosertib (DB11794)

IndicationStatusPhase
DBCOND0039586 (Stage IVB Oropharyngeal Squamous Cell Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02567422M6620, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaTreatment